Fourth Circuit Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 1 - 10 of 46
Eagle Pharmaceuticals, Inc. v. Accord Healthcare Inc. et al
as 5:2024cv00095
Plaintiff: Eagle Pharmaceuticals, Inc.
Defendant: Accord Healthcare Inc., Accord Healthcare Ltd. and Intas Pharmaceuticals Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MSN Laboratories Private Limited v. Bioprojet Societe Civile De Recherche
as 1:2023cv01675
Plaintiff: MSN Laboratories Private Limited
Defendant: Bioprojet Societe Civile De Recherche
Cause Of Action: 35 U.S.C. § 1 Patent Non-Infringement - Declaratory Judgment
Actelion Pharmaceuticals Ltd. et al v. Mylan Pharmaceuticals Inc.
as 1:2023cv00088
Plaintiff: Actelion Pharmaceuticals Ltd. and Actelion Pharmaceuticals US, Inc.
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PFIZER INC. et al v. SYNTHON PHARMACEUTICALS INC. et al
as 1:2023cv00936
Plaintiff: PFIZER INC., WARNER-LAMBERT COMPANY LLC, PF PRISM C.V. and others
Defendant: SYNTHON PHARMACEUTICALS, INC., SYNTHON B.V. and SYNTHON INTERNATIONAL HOLDING B.V.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2023cv00788
Plaintiff: Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals, Inc.
Defendant: BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant: Abraxis Bioscience, LLC
Defendant: Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. ACCORD HEALTHCARE, INC. et al
as 1:2023cv00157
Plaintiff: THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant: ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD. and INTAS PHARMACEUTICALS LTD.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Ferring Pharmaceuticals Inc. et al v. Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
as 3:2022cv00616
Plaintiff: Ferring Pharmaceuticals Inc., Ferring International Center S.A., Ferring B.V. and others
Defendant: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00089
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant: Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?